Consensus Cerence Inc.

Equities

CRNC

US1567271093

Market Closed - Nasdaq 04:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
4.99 USD -2.16% Intraday chart for Cerence Inc. -47.03% -74.62%

Evolution of the average Target Price on Cerence Inc.

Price target over the last 5 years

History of analyst recommendation changes

ad1e84f631.6X83QjsJRZiX5gG1XZMGELBDYFthDpE1AVlclZBbS58.uD11JFg7PcHAoHX_J9d0eN8xKWkPfdBtTwpqx6gBMd2ESVQgSzoy6rqENQ~0602ade1ea0b88309af104ac245b4a32
Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating MT
Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating MT
Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50 MT
Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating MT
Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating MT
Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22 MT
North American Morning Briefing : Rate Doubts Keep -2- DJ
Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating MT
Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept MT
Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating MT
Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating MT
Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating MT
Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating MT
Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating MT
Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating MT
Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating MT
Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating MT
Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating MT
Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating MT
Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating MT
Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40 MT
Goldman Sachs Raises PT on Cerence to $19 From $17 as Q4 Results Were "Modestly Above Consensus", Maintains Neutral Rating MT
Cowen Raises Price Target on Cerence to $35 From $32, Maintains Outperform Rating MT
Jefferies Adjusts Price Target on Cerence to $20 From $25, Maintains Hold Rating MT
Needham Adjusts Cerence's Price Target to $40 From $30, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
4.99 USD
Average target price
8.214 USD
Spread / Average Target
+64.62%
High Price Target
12 USD
Spread / Highest target
+140.48%
Low Price Target
6 USD
Spread / Lowest Target
+20.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cerence Inc.

Wells Fargo Securities
Wedbush
Baird
Craig-Hallum
Goldman Sachs
Needham & Co.
Jefferies & Co.
Cowen
RBC Capital Markets
Berenberg Bank
Raymond James
Evercore ISI
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. CRNC Stock
  4. Consensus Cerence Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW